Only 4 percent of U.S. gay men on PrEP: study


Washington Blade
by Staff Reports
September 11, 2018

LOS ANGELES — Only 4 percent of sexually active gay and bisexual men in the United States use Truvada, a highly effective medication used to prevent the transmission of HIV, according to the results of a first-of-its-kind study, MedicalXPress reports.

Led by Psychology Professor Phillip Hammack, the study was published Sept. 7 in the journal PLOS ONE.

Truvada is a once-a-day prescription medication used to reduce the risk of HIV infection; it is the only FDA-approved form of pre-exposure prophylaxis, or PrEP, which is recommended by the Centers for Disease Control and Prevention (CDC) for those at high risk of HIV/AIDS.

For the full article click here